Area of research
Infectious Diseases · Emergency Medical Services
Research interest
Research interests include Viral Infections and Outbreaks Research, Disaster Response and Management, Poxvirus research and outbreaks, and Herpesvirus Infections and Treatments.
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)
Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades
Detection of Marburg Virus Disease in Guinea
Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks
Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak
Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015—A Retrospective Observational Study
Virus genomes reveal factors that spread and sustained the Ebola epidemic
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus
Real-time, portable genome sequencing for Ebola surveillance
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Unique human immune signature of Ebola virus disease in Guinea
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015
Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014–2015
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping
KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
A single vertebrate DNA virus protein disarms invertebrate immunity to RNA virus infection
Emergence of Cowpox: Study of the Virulence of Clinical Strains and Evaluation of Antivirals